Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 3/20 | 0.43 |
| ▸ | LPAR3 | Q9UBY5 | 5/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.38 |
| ▸ | FDPS | P14324 | 5/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21291944 | 0.93 | SMPD1 (0.49) | SMPD1LPAR3LPAR1LPAR2FDPS | |
| SCHEMBL21291943 | 0.91 | SMPD1 (0.40) | SMPD1LPAR3LPAR1CYP3A4LPAR2 | |
| SCHEMBL2049378 | 0.89 | SMPD1 (0.56) | SMPD1LPAR3LPAR1CYP3A4LPAR2 | |
| SCHEMBL2519670 | 0.88 | SMPD1 (0.37) | SMPD1LPAR3LPAR1LPAR2FDPS | |
| SCHEMBL2049376 | 0.84 | CYP3A4 (0.46) | SMPD1LPAR3LPAR1CYP3A4TSHR | |
| SCHEMBL21291941 | 0.83 | LPAR3 (0.37) | SMPD1LPAR3LPAR1CYP3A4LPAR2 | |
| SCHEMBL11044258 | 0.82 | SMPD1 (0.42) | SMPD1LPAR3LPAR1CYP3A4LPAR2 | |
| SCHEMBL2380001 | 0.81 | SMPD1 (0.62) | SMPD1LPAR3LPAR1LPAR2FDPS | |
| SCHEMBL21291922 | 0.81 | SMPD1 (0.62) | SMPD1LPAR3LPAR1LPAR2FDPS | |
| SCHEMBL29026469 | 0.81 | SMPD1 (0.62) | SMPD1LPAR3LPAR1LPAR2FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11248011-B2 | Phosphorus-based releasing agent, optical polymerizable composition comprising same and preparation thereof | SKC CO., LTD. (KR) | 2022-02-15 | — | — | US | claimed |
| US-20190263846-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | SK PUCORE CO., LTD. (KR) | 2019-08-29 | — | — | US | claimed |
| EP-3530684-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | SKC Co., Ltd. (KR) | 2019-08-28 | — | — | EP | claimed |
| US-11248011-B2 | Phosphorus-based releasing agent, optical polymerizable composition comprising same and preparation thereof | SKC CO., LTD. (KR) | 2022-02-15 | — | — | US | disclosed |
| US-20190263846-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | SK PUCORE CO., LTD. (KR) | 2019-08-29 | — | — | US | disclosed |
| EP-3530684-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | SKC Co., Ltd. (KR) | 2019-08-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190263846-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | PMM2, PGM2, IPMK | SMPD1 3130/4885LPAR3 2839/4885LPAR1 1995/4885 |
| US-11248011-B2 | Phosphorus-based releasing agent, optical polymerizable composition comprising same and preparation thereof | PMM2, PGM2, IPMK | SMPD1 3130/4885LPAR3 2839/4885LPAR1 1995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.